| Serial Number | 97091070 |
| Word Mark | PREDICTSCRIPT |
| Filing Date | Monday, October 25, 2021 |
| Status | 748 - STATEMENT OF USE - TO EXAMINER |
| Status Date | Saturday, June 15, 2024 |
| Registration Number | 0000000 |
| Registration Date | NOT AVAILABLE |
| Mark Drawing | 4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form |
| Published for Opposition Date | Tuesday, September 19, 2023 |
| Pseudo Mark | PREDICT SCRIPT |
| Goods and Services | Scientific and technological services in the field of pharmaceuticals featuring scientific testing, analysis and evaluation of blood samples for the purpose of drug development by others, namely, data-driven analytics and reporting to developers of drugs; scientific and technological services in the field of pharmaceuticals featuring scientific testing, analysis and evaluation of blood samples for the purpose of improving quality in the field of healthcare services, specifically for improving the monitoring and diagnostics of quantitative patient drug exposure, the monitoring and diagnostics of patient drug compliance, data-driven analytics and reporting to providers of healthcare services in the field of pharmacovigilance activities, drug dosage recommendations, initial drug prescribing, and drug switching, all for research purposes and not for medical purposes; genetic testing for scientific research purposes, specifically pharmacogenomic testing, analysis, and evaluation of buccal, saliva and other biological samples for the purposes of analyzing how the genetic makeup of an individual affects their response to drugs, improving drug selection and dosage recommendations, selecting initial and subsequent medications, identifying drug-drug interactions, avoiding adverse drug reactions, developing clinical treatment decision support recommendations, and supporting other medical diagnostic products and prescription drugs; genetic testing for scientific research purposes, namely, analysis of multiple genes and genetic variants and their effect on drug response across multiple therapeutic areas, including but not limited to psychiatry, pain, cardiology, and oncology; scientific and technological services in the field of pharmaceuticals in the nature of scientific testing, analysis and evaluation of biological samples for research purposes, specifically research in the field of clinical trials, and research in the field of new drug development and drug repurposing |
| International Class | 042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software. |
| US Class Codes | 100, 101 |
| Class Status Code | 6 - Active |
| Class Status Date | Wednesday, January 4, 2023 |
| Primary Code | 042 |
| First Use Anywhere Date | Tuesday, January 31, 2023 |
| First Use In Commerce Date | Tuesday, January 31, 2023 |
| Party Name | Phenomics Health Inc. |
| Party Type | 20 - Owner at Publication |
| Legal Entity Type | 03 - Corporation |
| Address | Plymouth, MI 48170 |
| Party Name | Phenomics Health Inc. |
| Party Type | 10 - Original Applicant |
| Legal Entity Type | 03 - Corporation |
| Address | Plymouth, MI 48170 |
| Event Date | Event Description |
| Tuesday, July 5, 2022 | NON-FINAL ACTION WRITTEN |
| Thursday, October 28, 2021 | NEW APPLICATION ENTERED |
| Monday, November 8, 2021 | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED |
| Wednesday, June 15, 2022 | ASSIGNED TO EXAMINER |
| Tuesday, July 5, 2022 | NON-FINAL ACTION E-MAILED |
| Tuesday, July 5, 2022 | NOTIFICATION OF NON-FINAL ACTION E-MAILED |
| Wednesday, January 4, 2023 | TEAS RESPONSE TO OFFICE ACTION RECEIVED |
| Wednesday, January 4, 2023 | CORRESPONDENCE RECEIVED IN LAW OFFICE |
| Wednesday, January 4, 2023 | TEAS/EMAIL CORRESPONDENCE ENTERED |
| Friday, February 10, 2023 | FINAL REFUSAL WRITTEN |
| Friday, February 10, 2023 | FINAL REFUSAL E-MAILED |
| Friday, February 10, 2023 | NOTIFICATION OF FINAL REFUSAL EMAILED |
| Thursday, April 27, 2023 | APPLICATION EXTENSION TO RESPONSE PERIOD - RECEIVED |
| Thursday, April 27, 2023 | APPLICATION EXTENSION GRANTED/RECEIPT PROVIDED |
| Thursday, August 3, 2023 | TEAS REQUEST FOR RECONSIDERATION RECEIVED |
| Thursday, August 3, 2023 | CORRESPONDENCE RECEIVED IN LAW OFFICE |
| Thursday, August 3, 2023 | TEAS/EMAIL CORRESPONDENCE ENTERED |
| Tuesday, August 8, 2023 | EXPARTE APPEAL RECEIVED AT TTAB |
| Tuesday, August 8, 2023 | JURISDICTION RESTORED TO EXAMINING ATTORNEY |
| Tuesday, August 8, 2023 | EX PARTE APPEAL-INSTITUTED |
| Tuesday, August 15, 2023 | APPROVED FOR PUB - PRINCIPAL REGISTER |
| Wednesday, August 30, 2023 | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED |
| Tuesday, September 19, 2023 | PUBLISHED FOR OPPOSITION |
| Tuesday, September 19, 2023 | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED |
| Thursday, October 19, 2023 | EXPARTE APPEAL DISMISSED AS MOOT |
| Thursday, October 19, 2023 | EXPARTE APPEAL TERMINATED |
| Friday, October 20, 2023 | EXPARTE APPEAL TERMINATED |
| Tuesday, November 14, 2023 | NOA E-MAILED - SOU REQUIRED FROM APPLICANT |
| Friday, May 10, 2024 | SOU TEAS EXTENSION RECEIVED |
| Friday, May 10, 2024 | SOU EXTENSION 1 FILED |
| Friday, May 10, 2024 | SOU EXTENSION 1 GRANTED |
| Saturday, May 11, 2024 | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED |
| Monday, May 13, 2024 | USE AMENDMENT FILED |
| Monday, May 13, 2024 | TEAS STATEMENT OF USE RECEIVED |
| Saturday, June 15, 2024 | STATEMENT OF USE PROCESSING COMPLETE |
| Saturday, June 15, 2024 | CASE ASSIGNED TO INTENT TO USE PARALEGAL |